Atlas Trials

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

Clinical trial NCT01394835 · UNKNOWN

Trial details

NCT number
NCT01394835
Sponsor
Rabin Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung TransplantationBronchiolitis Obliterable Syndrome
Start date
2011-09-01
Primary completion
2012-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.